Yusuf Tanrıkulu, Hüsnü Alptekin, Kazım Gemici, Ahmet Okus, Barış Sevinç

Effectiveness of ursodeoxycholic acid for the treatment ofgall bladder stones and sludge in pregnant women

Aim: The objective of this study is to evaluate the effectiveness of ursodeoxycholic acid (UDCA) for the treatment of symptomaticpregnant women with gall bladder stones and/or sludge.Materials and Methods: Gynecology and obstetrics clinic patients who were symptomatic with gallbladder stones and/ormicrolithiasis were included in the study. Group 1 consisted of cases with conservative treatment and group 2 consisted of caseswith UDCA treatment. After treatment, the groups were compared for symptomatic and radiological relief and hospitalization.Results: For group 2, the mean treatment time with UDCA was 7.6 weeks. After treatment, a full cure was achieved in 28% of casesand symptomatic relief was achieved in 36% of cases. In group one; there was response to treatment in only 12% of cases. Inthe UDCA group, none of the patients needed hospitalization; however, in the conservative treatment group, five cases neededhospitalization.Conclusion: UDCA is effective for the treatment of symptomatic gall bladder disease in pregnancy. It both relieves symptoms anddecreases the need for hospitalization.

PDF

___

1. de Bari O, Wang TY, Liu M, et al. Cholesterol cholelithiasis in pregnant women: pathogenesis, prevention and treatment. Ann Hepatol 2014;13:728- 45.
2. Xiao ZL, Chen Q, Biancani P, et al. Mechanisms of gallbladder hypomotility in pregnant guinea pigs. Gastroenterology. 1999;116:411-9.
3. Bolukbas FF, Bolukbas C, Horoz M, et al. Risk factors associated with gallstone and biliary sludge formation during pregnancy. J Gastroenterol Hepatol 2006;21:1150-3.
4. del Avila-Silva MR, Zavala-Castillo JC, Coronel-Cruz FM. Laparoscopic cholecystectomy in pregnant patient: experience in hospital General de Mexico in a period of 5 years (2008-2012). Ginecol Obstet Mex 2014;82:509-17.
5. Ramin KD, Ramsey PS. Disease of the gallbladder and pancreas in pregnancy. Obstet Gynecol Clin North Am 2001;28:571-80.
6. Guarino MP, Cong P, Cicala M, et al. Ursodeoxycholic acid improves muscle contractility and inflammation in symptomatic gallbladders with cholesterol gallstones. Gut 2007;56:815-20.
7. I'lchenko AA, Orlova IuN. Effectiveness of ursodeoxycholic acid in cholesterosis of the gallbladder. Ter Arkh 2003;75:35-8.
8. Bouyou J, Gaujoux S, Marcellin L, et al. Abdominal emergencies during pregnancy. J Visc Surg 2015;152:105-15.
9. Ibitoye BO, Adisa AO, Makinde ON, et al. Prevalence and complications of gallstone disease among pregnant women in a Nigerian hospital. Int J Gynaecol Obstet 2014;125:41-3.
10. Jorge AM, Keswani RN, Veerappan A, et al. Non-operative management of smymptomatic cholelithiasis in pregnancy is associated with frequent hospitalizations. J Gastrointest Surg. 2015;19:598- 603.
11. Othman MO, Stone E, Hashimi M, et al. Conservative management of cholelithiasis and its complications in pregnancy is associated with recurrent symptoms and more emergency department visits. Gastrointest Endosc 2012;76:564-9.
12. Kuy S, Roman SA, Desai R, et al. Outcomes following cholecystectomy in pregnant and nonpregnant women. Surgery 2009;146:358-66.
13. Abate MA. Medical management of cholesterol gallstones. Drug Intell Clin Pharm 1986;20:106-15. 14. Salen G. Clinical perspective on the treatment of gallstones with ursodeoxycholic acid. J Clin Astronautical 1988;10:12-7.
15. O'Donnell LD, Heaton KW. Recurrence and rerecurrence of gall stones after medical dissolution: a longterm follow up. Gut 1988;29:655-8.
16. Mijnhout GS, Smulders YM, Craanen ME. Gallstones following considerable weight loss and recommendations for their prevention. Ned Tijdschr Geneeskd 2004;148:174-7.
17. Adams LB, Chang C, Pope J, et al. Randomized, Prospective Comparison of Ursodeoxycholic Acid for the Prevention of Gallstones after Sleeve Gastrectomy. Obes Surg 2016;26:990-4
18. Stokes CS, Gluud LL, Casper M, et al. Ursodeoxycholic acid and diets higher in fat prevent gallbladder stones during weight loss: a meta-analysis of randomized controlled trials. Clin Gastroenterol Hepatol 2014;12:1090-100.
19. Nishizawa T, Suzuki H, Takahashi M, et al. Effect of ursodeoxycholic acid and endoscopic sphincterotomy in long-term stenting for common bile duct stones. J Gastroenterol Hepatol 2013;28:63-7.
20. Guarino MP, Carotti S, Sarzano M, et al. Short-term ursodeoxycholic acid treatment improves gallbladder bile turnover in gallstone patients: a randomized trial. Neurogastroenterol Motil 2005;17:680-6.
21. Venneman NG, Besselink MG, Keulemans YC, et al. Ursodeoxycholic acid exerts no beneficial effect in patients with symptomatic gallstones awaiting cholecystectomy. Hepatology 2006;43:1276-83.
22. Joutsiniemi T, Timonen S, Linden M, et al. Intrahepatic cholestasis of pregnancy: observational study of the treatment with low-doseursodeoxycholic acid. BMC Gastroenterol 2015;15:92.
23. Grymowicz M, Czajkowski K, Smolarczyk R. Pregnancy course in patients with intrahepatic cholestasis of pregnancy treated with very low doses of ursodeoxycholic acid. Scand J Gastroenterol 2016;51:78-85.